Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical cefazolin for reducing post-cesarean section infection
IRCT2017092436376N1Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Sep 2017
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cefazolin in surgical site infection (SSI) (2 arms), sponsored by Sabzevar University of Medical Sciences. Started Sep 2017; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT2017092436376N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017092436376N1.